Based on the reported evidence that oxLDL was one of the major ligands of CD36 as well as the studies to validate the critical role of oxLDL in NAFLD development13, we further observed a higher level of oxLDL that contributes to Nogo-B induction in NASH mice. This evidence concerns the gene CD36 and metabolic dysfunction-associated steatotic liver disease.